Cellular uptake of PLGA nanoparticles targeted with anti-amyloid and anti-transferrin receptor antibodies for Alzheimer's disease treatment
During the last few decades, relevant efforts have been reported to design nanocarriers for drug transport through the blood brain barrier (BBB). New drugs, such as peptide iAβ5, capable to inhibit the aggregates associated with Alzheimeŕs disease (AD) are being tested but the most frequent drawbac...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
20 April 2016
|
| In: |
Colloids and surfaces. B, Biointerfaces
Year: 2016, Volume: 145, Pages: 8-13 |
| ISSN: | 1873-4367 |
| DOI: | 10.1016/j.colsurfb.2016.04.041 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.colsurfb.2016.04.041
|
| Author Notes: | Joana A. Loureiro, Bárbara Gomes, Gert Fricker, Manuel A.N. Coelho, Sandra Rocha, Maria Carmo Pereira |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1698490917 | ||
| 003 | DE-627 | ||
| 005 | 20230427091658.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 200518s2016 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.colsurfb.2016.04.041 |2 doi | |
| 035 | |a (DE-627)1698490917 | ||
| 035 | |a (DE-599)KXP1698490917 | ||
| 035 | |a (OCoLC)1341325669 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 32 |2 sdnb | ||
| 100 | 1 | |a Loureiro, Joana A. |e VerfasserIn |0 (DE-588)1210452782 |0 (DE-627)1698491980 |4 aut | |
| 245 | 1 | 0 | |a Cellular uptake of PLGA nanoparticles targeted with anti-amyloid and anti-transferrin receptor antibodies for Alzheimer's disease treatment |c Joana A. Loureiro, Bárbara Gomes, Gert Fricker, Manuel A.N. Coelho, Sandra Rocha, Maria Carmo Pereira |
| 264 | 1 | |c 20 April 2016 | |
| 300 | |a 6 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 18.05.2020 | ||
| 520 | |a During the last few decades, relevant efforts have been reported to design nanocarriers for drug transport through the blood brain barrier (BBB). New drugs, such as peptide iAβ5, capable to inhibit the aggregates associated with Alzheimeŕs disease (AD) are being tested but the most frequent drawback is to reach the brain in the desired concentrations due to the low BBB permeability-surface area. Our approach, as a proof of concept to improve drug transport through the BBB, is based on poly(lactic-co-glycolic acid) (PLGA) nanoparticles with surface functionalized with anti-transferrin receptor monoclonal antibody (OX26) and anti-Aβ (DE2B4) to deliver encapsulated iAβ5 into the brain. Porcine brain capillary endothelial cells (PBCECs) were used as a BBB model to evaluate the system efficacy and toxicity. The uptake of immune nanoparticles with a controlled delivery of the peptide iAβ5 was substantially increased compared to the nanoparticles (NPs) without monoclonal antibody functionalization. | ||
| 650 | 4 | |a Alzheimer Disease | |
| 650 | 4 | |a Alzheimer’s disease | |
| 650 | 4 | |a Amyloid | |
| 650 | 4 | |a Animals | |
| 650 | 4 | |a Antibodies | |
| 650 | 4 | |a Blood brain-barrier | |
| 650 | 4 | |a Blood-Brain Barrier | |
| 650 | 4 | |a Brain | |
| 650 | 4 | |a Drug delivery systems | |
| 650 | 4 | |a Immuno nanoparticles | |
| 650 | 4 | |a Lactic Acid | |
| 650 | 4 | |a Nanoparticles | |
| 650 | 4 | |a Polyglycolic Acid | |
| 650 | 4 | |a Polylactic Acid-Polyglycolic Acid Copolymer | |
| 650 | 4 | |a Receptors, Transferrin | |
| 650 | 4 | |a Swine | |
| 650 | 4 | |a Therapeutic peptides | |
| 700 | 1 | |a Gomes, Bárbara |e VerfasserIn |4 aut | |
| 700 | 1 | |a Fricker, Gert |d 1956- |e VerfasserIn |0 (DE-588)1042227675 |0 (DE-627)768469465 |0 (DE-576)393783464 |4 aut | |
| 700 | 1 | |a Coelho, Manuel A. N. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Rocha, Sandra |e VerfasserIn |4 aut | |
| 700 | 1 | |a Pereira, Maria Carmo |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Colloids and surfaces. B, Biointerfaces |d Amsterdam [u.a.] : Elsevier Science, 1993 |g 145(2016), Seite 8-13 |h Online-Ressource |w (DE-627)306660016 |w (DE-600)1500523-9 |w (DE-576)098614851 |x 1873-4367 |7 nnas |a Cellular uptake of PLGA nanoparticles targeted with anti-amyloid and anti-transferrin receptor antibodies for Alzheimer's disease treatment |
| 773 | 1 | 8 | |g volume:145 |g year:2016 |g pages:8-13 |g extent:6 |a Cellular uptake of PLGA nanoparticles targeted with anti-amyloid and anti-transferrin receptor antibodies for Alzheimer's disease treatment |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.colsurfb.2016.04.041 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20200518 | ||
| 993 | |a Article | ||
| 994 | |a 2016 | ||
| 998 | |g 1042227675 |a Fricker, Gert |m 1042227675:Fricker, Gert |d 160000 |d 160100 |e 160000PF1042227675 |e 160100PF1042227675 |k 0/160000/ |k 1/160000/160100/ |p 3 | ||
| 999 | |a KXP-PPN1698490917 |e 366828122X | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"language":["eng"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"origin":[{"dateIssuedKey":"2016","dateIssuedDisp":"20 April 2016"}],"physDesc":[{"extent":"6 S."}],"relHost":[{"type":{"media":"Online-Ressource","bibl":"periodical"},"origin":[{"publisherPlace":"Amsterdam [u.a.] ; [Erscheinungsort nicht ermittelbar]","dateIssuedKey":"1993","publisher":"Elsevier Science ; Science Direct","dateIssuedDisp":"1993-"}],"physDesc":[{"extent":"Online-Ressource"}],"part":{"extent":"6","volume":"145","text":"145(2016), Seite 8-13","pages":"8-13","year":"2016"},"language":["eng"],"note":["Gesehen am 23.11.2020"],"disp":"Cellular uptake of PLGA nanoparticles targeted with anti-amyloid and anti-transferrin receptor antibodies for Alzheimer's disease treatmentColloids and surfaces. B, Biointerfaces","title":[{"subtitle":"an international journal devoted to fundamental and applied research on colloid and interfacial phenomena in relation to systems of biological origin","partname":"Biointerfaces","title":"Colloids and surfaces","title_sort":"Colloids and surfaces"}],"recId":"306660016","id":{"issn":["1873-4367"],"zdb":["1500523-9"],"eki":["306660016"]},"titleAlt":[{"title":"Colloids and surfaces / B"}],"pubHistory":["1.1993 - 88.2011; Vol. 89.2012 -"]}],"recId":"1698490917","id":{"doi":["10.1016/j.colsurfb.2016.04.041"],"eki":["1698490917"]},"person":[{"given":"Joana A.","display":"Loureiro, Joana A.","roleDisplay":"VerfasserIn","role":"aut","family":"Loureiro"},{"family":"Gomes","role":"aut","given":"Bárbara","roleDisplay":"VerfasserIn","display":"Gomes, Bárbara"},{"family":"Fricker","role":"aut","display":"Fricker, Gert","roleDisplay":"VerfasserIn","given":"Gert"},{"role":"aut","family":"Coelho","given":"Manuel A. N.","roleDisplay":"VerfasserIn","display":"Coelho, Manuel A. N."},{"family":"Rocha","role":"aut","roleDisplay":"VerfasserIn","display":"Rocha, Sandra","given":"Sandra"},{"display":"Pereira, Maria Carmo","roleDisplay":"VerfasserIn","given":"Maria Carmo","family":"Pereira","role":"aut"}],"note":["Gesehen am 18.05.2020"],"name":{"displayForm":["Joana A. Loureiro, Bárbara Gomes, Gert Fricker, Manuel A.N. Coelho, Sandra Rocha, Maria Carmo Pereira"]},"title":[{"title":"Cellular uptake of PLGA nanoparticles targeted with anti-amyloid and anti-transferrin receptor antibodies for Alzheimer's disease treatment","title_sort":"Cellular uptake of PLGA nanoparticles targeted with anti-amyloid and anti-transferrin receptor antibodies for Alzheimer's disease treatment"}]} | ||
| SRT | |a LOUREIROJOCELLULARUP2020 | ||